Publisher
Springer International Publishing
Reference23 articles.
1. American Psychiatric Association (2013) Diagnosis and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Arlington
2. Edinger JD, Fins AI, Glenn DM, Sullivan RJ Jr, Bastian LA, Marsh GR, Dailey D, Hope TV, Young M, Shaw E, Vasilas D (2000) Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints? J Consult Clin Psychol 68:586–589
3. EdluarTM (zolpidem tartrate) sublingual tablets, CIV (2009) Prescribing information. Meda Pharmaceuticals Inc., Somerset, NJ; May 2009.
http://www.edluar.com/EDLUAR-PI.pdf
4. Farkas RH, Unger EF, Temple R (2013) Zolpidem and driving impairment. Identifying persons at risk. N Engl J Med 369:689–691
5. FDA Drug Safety Communication (2013) Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist); Jan 2013.
http://www.fda.gov/Drugs/DrugSafety/ucm334033.htm
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Zolpidem’s use for insomnia;Asian Journal of Psychiatry;2017-02